top of page
The Professional Network for Healthcare Experts
Sudarshan Pharma approves acquisition of 9.5% stake in MedTherapy Biotechnology
Sudarshan Pharma has approved the acquisition of a 9.5% stake in US-based MedTherapy Biotechnology, expanding its exposure to oncology cell and gene therapy.
nuaxia
19 hours ago2 min read
Cureety acquires Reimagine Care to expand precision oncology platform
The acquisition combines Cureety's therapy-specific oncology monitoring platform with Reimagine Care's AI-enabled virtual cancer-care capabilities.
nuaxia
5 days ago2 min read
bottom of page